Etesian Wealth Advisors Inc. Sells 21 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Etesian Wealth Advisors Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the third quarter, HoldingsChannel.com reports. The fund owned 913 shares of the healthcare conglomerate’s stock after selling 21 shares during the quarter. Etesian Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $534,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Key Client Fiduciary Advisors LLC boosted its stake in UnitedHealth Group by 14.1% during the third quarter. Key Client Fiduciary Advisors LLC now owns 485 shares of the healthcare conglomerate’s stock valued at $284,000 after buying an additional 60 shares during the last quarter. Clarity Wealth Advisors LLC boosted its stake in UnitedHealth Group by 12.6% during the third quarter. Clarity Wealth Advisors LLC now owns 581 shares of the healthcare conglomerate’s stock valued at $340,000 after buying an additional 65 shares during the last quarter. Alpha Financial Advisors LLC purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $223,000. Legacy Financial Strategies LLC raised its position in UnitedHealth Group by 4.5% during the third quarter. Legacy Financial Strategies LLC now owns 607 shares of the healthcare conglomerate’s stock valued at $355,000 after purchasing an additional 26 shares during the period. Finally, Raymond James & Associates raised its position in UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after purchasing an additional 587,088 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on UNH. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday. Barclays raised their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday. Finally, Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $615.58.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $569.61 on Friday. The firm’s fifty day moving average price is $584.42 and its 200 day moving average price is $534.15. The company has a market capitalization of $524.26 billion, a price-to-earnings ratio of 34.82, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.